AADI Aadi Bioscience | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Burns
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.85
-1.1% | | Neutral | |
ACLX Arcellx | Initiated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.23
+0.9% | $85.00 | Outperform | |
ACRV Acrivon Therapeutics | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.34
-1.7% | $20.00 ➝ $22.00 | Buy ➝ Buy | |
AEP American Electric Power | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.77
-0.8% | $95.00 ➝ $99.00 | Outperform ➝ Outperform | |
AGYS Agilysys | Target Raised by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.38
+13.9% | $95.00 ➝ $100.00 | Outperform ➝ Outperform | |
AGYS Agilysys | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $91.38
+13.9% | $100.00 | Buy ➝ Buy | |
Free report reveals “two-baggers” for 2024 (Ad) We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable. Download your free report today! |
AIR AAR | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.28
+0.7% | $81.00 ➝ $86.00 | Buy ➝ Buy | |
AIRS AirSculpt Technologies | Downgraded by | SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.53
-3.0% | $8.25 ➝ $5.00 | Outperform ➝ Market Perform | |
AJG Arthur J. Gallagher & Co. | Target Raised by | Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $249.91
+0.2% | $264.00 ➝ $270.00 | Buy ➝ Buy | |
AKYA Akoya Biosciences | Target Lowered by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.87
-30.3% | $9.00 ➝ $6.00 | Buy ➝ Buy | |
AKYA Akoya Biosciences | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.87
-30.3% | $10.00 ➝ $6.00 | Buy ➝ Buy | |
ALLO Allogene Therapeutics | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.90
| $4.40 ➝ $4.60 | Hold ➝ Hold | |
ALT Altimmune | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.92
+7.5% | $12.00 | Buy ➝ Buy | |
AMC AMC Entertainment | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.81
+31.2% | $3.10 ➝ $3.20 | Sell ➝ Sell | |
AMLX Amylyx Pharmaceuticals | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.87
+2.5% | $4.00 ➝ $3.00 | Neutral ➝ Neutral | |
AMRC Ameresco | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.42
+6.5% | $36.00 ➝ $39.00 | Buy ➝ Buy | |
ANNX Annexon | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.82
-1.0% | $30.00 | Buy ➝ Buy | |
AOMR Angel Oak Mortgage REIT | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.00
+2.0% | $10.00 ➝ $10.50 | Neutral ➝ Neutral | |
APA APA | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.11
-0.3% | $35.00 ➝ $33.00 | Neutral ➝ Neutral | |
APRE Aprea Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.77
+3.2% | $20.00 | Buy ➝ Buy | |
ARIS Aris Water Solutions | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.65
+2.1% | $16.00 ➝ $20.00 | Outperform ➝ Outperform | |
ASPN Aspen Aerogels | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.97
-5.0% | $29.00 ➝ $30.00 | Overweight ➝ Overweight | |
ATO Atmos Energy | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.24
+0.8% | $121.00 ➝ $129.00 | Equal Weight ➝ Equal Weight | |
ATO Atmos Energy | Upgraded by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.24
+0.8% | $130.00 ➝ $132.00 | Equal Weight ➝ Overweight | |
ATOS Atossa Therapeutics | Reiterated by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.54
+5.6% | | Overweight | |
AUGX Augmedix | Target Lowered by | Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.13
-51.7% | $8.00 ➝ $3.50 | Buy ➝ Buy | |
AUGX Augmedix | Downgraded by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.13
-51.7% | $5.00 ➝ $1.50 | Outperform ➝ Inline | |
AUGX Augmedix | Downgraded by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.13
-51.7% | $5.00 ➝ $5.00 | Buy ➝ Hold | |
AVB AvalonBay Communities | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.68
+0.4% | $193.00 ➝ $213.00 | Sector Perform ➝ Sector Perform | |
AVB AvalonBay Communities | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.68
+0.4% | $203.00 ➝ $209.00 | Overweight ➝ Overweight | |
AVB AvalonBay Communities | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.68
+0.4% | $199.00 ➝ $210.00 | Neutral ➝ Neutral | |
AVTE Aerovate Therapeutics | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | L. Chico
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $19.50
+1.9% | $41.00 | Outperform ➝ Outperform | |
BANC Banc of California | Target Lowered by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.98
+3.4% | $16.00 ➝ $15.00 | Equal Weight ➝ Equal Weight | |
BBIO BridgeBio Pharma | Initiated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.08
+2.0% | $50.00 | Outperform | |
BJ BJ's Wholesale Club | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.25
-1.6% | $76.00 ➝ $78.00 | In-Line ➝ In-Line | |
BMRN BioMarin Pharmaceutical | Initiated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $79.61
-1.1% | $113.00 | Outperform | |
BNTX BioNTech | Initiated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.17
-0.6% | $100.00 | Inline | |
BPMC Blueprint Medicines | Initiated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.70
-2.2% | $140.00 | Overweight | |
BRP The Baldwin Insurance Group | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.33
+0.9% | $35.00 ➝ $37.00 | Buy ➝ Buy | |
BTM Bitcoin Depot | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.89
-4.8% | $4.00 | Buy ➝ Buy | |
Does this make you sick? (Ad) The US Dollar Is "Finished"
A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit |
BYON Beyond | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.85
+0.3% | $37.00 | Outperform ➝ Outperform | |
CALC CalciMedica | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Pantginis
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.32
+2.3% | $20.00 | Buy ➝ Buy | |
CAPR Capricor Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.18
-4.8% | $40.00 | Buy ➝ Buy | |
CAPR Capricor Therapeutics | Target Raised by | LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.18
-4.8% | $24.00 ➝ $25.00 | Buy ➝ Buy | |
CAPR Capricor Therapeutics | Reiterated by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.18
-4.8% | $8.00 | Overweight ➝ Overweight | |
CARA Cara Therapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.72
-4.5% | $5.00 | Buy ➝ Buy | |
CCEP Coca-Cola Europacific Partners | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.82
+0.5% | $78.00 ➝ $84.00 | Overweight ➝ Overweight | |
CCL Carnival Co. & | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.63
+0.5% | $20.00 ➝ $21.00 | Buy ➝ Buy | |
CE Celanese | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $159.75
-0.3% | $153.00 ➝ $158.00 | Market Perform ➝ Market Perform | |
CHRD Chord Energy | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $181.57
+0.3% | $230.00 ➝ $231.00 | Overweight ➝ Overweight | |
CHUY Chuy's | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.18
-0.9% | $36.00 ➝ $32.00 | Hold ➝ Hold | |
CINT CI&T | Initiated by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.54
+0.6% | $4.20 | Neutral | |
CMPX Compass Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.62
+3.8% | $10.00 | Buy ➝ Buy | |
CMS CMS Energy | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.32
-0.1% | $68.00 ➝ $71.00 | Outperform ➝ Outperform | |
COCP Cocrystal Pharma | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.90
+9.8% | $10.00 | Buy ➝ Buy | |
COST Costco Wholesale | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $776.87
+0.2% | $810.00 ➝ $820.00 | Outperform ➝ Outperform | |
CPT Camden Property Trust | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $107.07
+0.3% | $105.00 ➝ $109.00 | Neutral ➝ Neutral | |
CPT Camden Property Trust | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $107.07
+0.3% | $98.00 ➝ $105.50 | Equal Weight ➝ Equal Weight | |
CPT Camden Property Trust | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $107.07
+0.3% | $104.00 ➝ $108.00 | Sector Perform ➝ Sector Perform | |
CRDL Cardiol Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | V. Bernardino
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.19
+0.5% | $9.00 | Buy ➝ Buy | |
CRH CRH | Initiated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $82.75
+0.8% | $110.00 | Outperform | |
CRNX Crinetics Pharmaceuticals | Reiterated by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.21
+2.7% | $65.00 | Overweight ➝ Overweight | |
CRWD CrowdStrike | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $329.19
+3.1% | $400.00 | Market Outperform ➝ Market Outperform | |
CTRA Coterra Energy | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.00
+0.1% | $37.00 ➝ $39.00 | Overweight ➝ Overweight | |
CVI CVR Energy | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.55
| $37.00 ➝ $33.75 | Neutral ➝ Neutral | |
CVNA Carvana | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.55
+3.1% | $135.00 | Market Outperform ➝ Market Outperform | |
CWEN Clearway Energy | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.33
+1.6% | $25.00 ➝ $30.00 | Outperform ➝ Outperform | |
CX CEMEX | Initiated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.86
-1.1% | $9.00 | Underperform | |
CYBR CyberArk Software | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $238.90
+2.1% | $280.00 | Market Outperform ➝ Market Outperform | |
CYTK Cytokinetics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.54
+2.9% | $94.00 | Buy ➝ Buy | |
DCBO Docebo | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.41
+3.2% | $65.00 ➝ $55.00 | Buy ➝ Buy | |
DCBO Docebo | Target Lowered by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.41
+3.2% | $65.00 ➝ $50.00 | Sector Outperform ➝ Sector Outperform | |
DCTH Delcath Systems | Initiated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.12
+31.9% | $25.00 | Overweight | |
DDD 3D Systems | Reiterated by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Jensen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.98
+6.7% | $8.25 | Overweight ➝ Overweight | |
DH Definitive Healthcare | Reiterated by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.47
+0.7% | | Outperform | |
DINO HF Sinclair | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.51
+0.5% | $70.00 ➝ $65.00 | Overweight ➝ Overweight | |
DK Delek US | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.53
+0.1% | $31.00 ➝ $30.00 | Neutral ➝ Neutral | |
DLX Deluxe | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.63
+3.1% | $33.00 ➝ $35.00 | Buy ➝ Buy | |
DNB Dun & Bradstreet | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.67
+1.1% | $17.00 | Buy ➝ Buy | |
DRD DRDGOLD | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.60
+0.7% | $13.25 ➝ $15.50 | Buy ➝ Buy | |
DRQ Dril-Quip | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.02
-1.1% | $22.00 ➝ $21.00 | Underweight ➝ Underweight | |
DSGX The Descartes Systems Group | Initiated by | Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.49
-2.0% | $90.00 | Neutral | |
DVN Devon Energy | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.74
-0.3% | $60.00 ➝ $61.00 | Overweight ➝ Overweight | |
EHAB Enhabit | Upgraded by | SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.87
+2.7% | $8.50 | Underperform ➝ Market Perform | |
EIX Edison International | Upgraded by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.95
+0.7% | $72.00 ➝ $86.00 | Equal Weight ➝ Overweight | |
ELEV Elevation Oncology | Initiated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.55
+0.3% | $8.00 | Overweight | |
EOG EOG Resources | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $129.32
-0.1% | $153.00 ➝ $154.00 | Overweight ➝ Overweight | |
EPAM EPAM Systems | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $187.59
-1.6% | $345.00 ➝ $258.00 | Buy ➝ Buy | |
EQR Equity Residential | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.30
+0.8% | $65.00 ➝ $72.00 | Sector Perform ➝ Sector Perform | |
EQR Equity Residential | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.30
+0.8% | $68.00 ➝ $70.00 | Equal Weight ➝ Equal Weight | |
Automatic Income (from home) (Ad) Everyone’s talking about this new income hack that could generate triple digit returns on your money.
But here’s the best part… Watch this short video |
EQR Equity Residential | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.30
+0.8% | $73.00 ➝ $75.00 | Buy ➝ Buy | |
ESS Essex Property Trust | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $264.17
+1.4% | $250.00 ➝ $261.00 | Neutral ➝ Neutral | |
ESS Essex Property Trust | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $264.17
+1.4% | $230.00 ➝ $250.00 | Equal Weight ➝ Equal Weight | |
ESS Essex Property Trust | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $264.17
+1.4% | $256.00 ➝ $283.00 | Sector Outperform ➝ Sector Outperform | |
EVBG Everbridge | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.76
+0.1% | $29.00 ➝ $35.00 | Neutral ➝ Neutral | |
EVRG Evergy | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.33
-0.7% | $56.00 ➝ $61.00 | Overweight ➝ Overweight | |
EW Edwards Lifesciences | Upgraded by | Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $86.02
+1.6% | $86.00 ➝ $103.00 | Hold ➝ Buy | |
EXEL Exelixis | Initiated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.93
-1.6% | $23.00 | Equal Weight | |
EXPD Expeditors International of Washington | Upgraded by | BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.40
-0.2% | $112.00 | Underperform ➝ Neutral | |
FCX Freeport-McMoRan | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.24
+2.3% | $41.00 ➝ $54.00 | Neutral ➝ Neutral | |
FF FutureFuel | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.98
-1.0% | $0.70 ➝ $0.80 | Buy ➝ Buy | |
FIHL Fidelis Insurance | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.46
+3.0% | $22.50 ➝ $22.00 | Buy ➝ Buy | |
FLUX Flux Power | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.45
+7.1% | $15.00 | Buy ➝ Buy | |
FND Floor & Decor | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $123.25
+0.6% | $120.00 ➝ $125.00 | In-Line ➝ In-Line | |
FOLD Amicus Therapeutics | Upgraded by | Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.35
+3.4% | $13.00 | Neutral ➝ Buy | |
FTRE Fortrea | Upgraded by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.79
+2.4% | $45.00 ➝ $36.00 | Neutral ➝ Outperform | |
FTRE Fortrea | Target Lowered by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.79
+2.4% | $33.00 ➝ $27.00 | Underperform ➝ Underperform | |
FTRE Fortrea | Target Lowered by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.79
+2.4% | $43.00 ➝ $31.00 | Outperform ➝ Outperform | |
FULC Fulcrum Therapeutics | Target Lowered by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.79
+6.0% | $16.00 ➝ $14.00 | Outperform ➝ Outperform | |
FULC Fulcrum Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.79
+6.0% | $17.00 | Buy ➝ Buy | |
GBIO Generation Bio | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.61
+27.1% | $5.00 | Outperform ➝ Outperform | |
GBIO Generation Bio | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.61
+27.1% | $10.00 | Buy ➝ Buy | |
GRMN Garmin | Target Raised by | Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.92
+0.3% | $175.00 ➝ $210.00 | Strong-Buy ➝ Strong-Buy | |
GXO GXO Logistics | Reiterated by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.52
-0.6% | $70.00 | Overweight | |
HD Home Depot | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $340.11
-0.2% | $415.00 ➝ $420.00 | Outperform ➝ Outperform | |
HD Home Depot | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $340.11
-0.2% | $360.00 ➝ $360.00 | Market Perform ➝ Market Perform | |
HLI Houlihan Lokey | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $137.15
+0.9% | $157.00 ➝ $145.00 | Buy ➝ Buy | |
HQI HireQuest | Target Lowered by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.24
+3.2% | $19.00 ➝ $16.00 | Outperform ➝ Outperform | |
IAC IAC | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.92
+2.9% | $82.00 ➝ $84.00 | Overweight ➝ Overweight | |
IBP Installed Building Products | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $230.16
+0.8% | $250.00 ➝ $270.00 | Buy ➝ Buy | |
IDN Intellicheck | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.05
+3.4% | $5.00 | Buy ➝ Buy | |
IDXX IDEXX Laboratories | Target Lowered by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $519.06
+3.2% | $620.00 ➝ $596.00 | Overweight ➝ Overweight | |
IKNA Ikena Oncology | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.33
+0.8% | $8.00 | Outperform ➝ Outperform | |
IMNN Imunon | Target Lowered by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.35
-8.8% | $13.00 ➝ $12.00 | Buy ➝ Buy | |
INKT MiNK Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.12
+13.9% | $9.00 | Buy ➝ Buy | |
INO Inovio Pharmaceuticals | Initiated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.69
+2.9% | $20.00 | Overweight | |
INSM Insmed | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.52
-1.2% | $52.00 | Buy ➝ Buy | |
ITRM Iterum Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Arce
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.53
+0.7% | $6.00 | Buy ➝ Buy | |
IVVD Invivyd | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.41
+1.7% | $15.00 | Buy ➝ Buy | |
JACK Jack in the Box | Reiterated by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.22
+0.3% | $73.00 | Hold ➝ Hold | |
JBI Janus International Group | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.91
+0.7% | $21.00 | Buy ➝ Buy | |
JXN Jackson Financial | Downgraded by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.95
-0.5% | $75.00 ➝ $80.00 | Outperform ➝ Market Perform | |
KBR KBR | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.14
-0.1% | $68.00 ➝ $77.00 | Buy ➝ Buy | |
KNTK Kinetik | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.05
+0.7% | $37.00 ➝ $40.00 | Equal Weight ➝ Equal Weight | |
KURA Kura Oncology | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.83
+1.1% | $32.00 | Buy ➝ Buy | |
LAC Lithium Americas | Target Lowered by | Eight Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.52
+2.7% | $13.50 ➝ $10.00 | Buy | |
LEGN Legend Biotech | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.05
+2.5% | $85.00 ➝ $86.00 | Outperform ➝ Outperform | |
LIFE aTyr Pharma | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.78
+4.7% | $35.00 | Buy ➝ Buy | |
LLY Eli Lilly and Company | Target Raised by | Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $761.94
+0.6% | $770.00 ➝ $840.00 | Buy ➝ Buy | |
LOW Lowe's Companies | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $230.68
-1.0% | $245.00 ➝ $250.00 | In-Line ➝ In-Line | |
Automatic Income (from home) (Ad) Everyone’s talking about this new income hack that could generate triple digit returns on your money.
But here’s the best part… Watch this short video |
LPTX Leap Therapeutics | Target Lowered by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.81
-0.7% | $7.00 ➝ $5.50 | Buy ➝ Buy | |
LQDT Liquidity Services | Reiterated by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.15
+0.8% | $27.00 ➝ $27.00 | Outperform ➝ Outperform | |
MAA Mid-America Apartment Communities | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.97
+0.7% | $139.00 ➝ $144.00 | Sector Perform ➝ Sector Perform | |
MAA Mid-America Apartment Communities | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.97
+0.7% | $126.00 ➝ $131.00 | Sell ➝ Sell | |
MANH Manhattan Associates | Initiated by | Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $215.71
+1.0% | $260.00 | Buy | |
MITK Mitek Systems | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.76
-3.0% | $19.00 | Buy ➝ Buy | |
MP MP Materials | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.30
+11.9% | $30.00 | Buy ➝ Buy | |
MPC Marathon Petroleum | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $172.42
-3.1% | $204.00 ➝ $190.00 | Neutral ➝ Neutral | |
MPW Medical Properties Trust | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.90
+5.7% | $5.00 | Outperform ➝ Sector Perform | |
MRNA Moderna | Initiated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.64
+1.6% | $120.00 | In-Line | |
MSDL Morgan Stanley Direct Lending | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.49
+0.7% | $22.00 ➝ $21.00 | Equal Weight ➝ Equal Weight | |
MSDL Morgan Stanley Direct Lending | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.49
+0.7% | $22.00 ➝ $21.00 | Equal Weight ➝ Equal Weight | |
NBIX Neurocrine Biosciences | Initiated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $137.01
+0.6% | $175.00 | Outperform | |
NDAQ Nasdaq | Target Raised by | Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.45
-0.3% | $64.00 ➝ $66.00 | Buy ➝ Buy | |
NET Cloudflare | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.19
-0.5% | $120.00 | Market Outperform ➝ Market Outperform | |
NI NiSource | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.87
+0.2% | $30.00 ➝ $31.00 | Overweight ➝ Overweight | |
NNI Nelnet | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $109.68
+6.2% | $90.00 ➝ $96.00 | Hold ➝ Hold | |
NOG Northern Oil and Gas | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.88
+0.7% | $42.00 ➝ $43.00 | Neutral ➝ Neutral | |
NOTV Inotiv | Downgraded by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.07
-50.4% | $11.50 ➝ $3.75 | Buy ➝ Hold | |
NRIX Nurix Therapeutics | Initiated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.06
+8.0% | $20.00 | Overweight | |
NRIX Nurix Therapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.06
+8.0% | $31.00 | Buy ➝ Buy | |
NTRA Natera | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.69
+2.3% | $110.00 ➝ $120.00 | Overweight ➝ Overweight | |
NVDA NVIDIA | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $914.14
+1.1% | $970.00 ➝ $1,150.00 | Overweight ➝ Overweight | |
NWL Newell Brands | Upgraded by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.68
+5.3% | $8.00 | Underweight ➝ Equal Weight | |
OABI OmniAb | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.47
-0.2% | $8.00 | Buy ➝ Buy | |
OII Oceaneering International | Reiterated by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.43
+0.6% | $22.00 ➝ $21.00 | Equal Weight ➝ Underweight | |
ONCY Oncolytics Biotech | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.19
+1.7% | $5.00 | Buy ➝ Buy | |
ORA Ormat Technologies | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.78
+3.0% | $95.00 ➝ $100.00 | Buy ➝ Buy | |
ORLY O'Reilly Automotive | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $999.94
-1.3% | $1,255.00 ➝ $1,275.00 | Outperform ➝ Outperform | |
ORN Orion Group | Initiated by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.94
+2.8% | $14.00 | Buy | |
OWL Blue Owl Capital | Reiterated by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.53
+0.8% | $21.00 | Buy | |
PAA Plains All American Pipeline | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.36
+0.1% | $17.00 ➝ $18.00 | Sector Perform ➝ Sector Perform | |
PACS PACS Group | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.90
+7.3% | $31.00 | Overweight ➝ Overweight | |
PANW Palo Alto Networks | Target Lowered by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $300.96
-0.4% | $405.00 ➝ $385.00 | Outperform ➝ Outperform | |
PANW Palo Alto Networks | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $300.96
-0.4% | $380.00 | Market Outperform ➝ Market Outperform | |
PARR Par Pacific | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.27
-1.3% | $47.00 ➝ $43.00 | Overweight ➝ Overweight | |
PAYO Payoneer Global | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.82
+1.2% | $9.00 | Buy ➝ Buy | |
PBF PBF Energy | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $47.81
-0.3% | $61.00 ➝ $54.00 | Neutral ➝ Neutral | |
PLNT Planet Fitness | Upgraded by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.61
+0.1% | $68.00 ➝ $78.00 | Neutral ➝ Overweight | |
PLUG Plug Power | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.54
+22.5% | $18.00 | Buy ➝ Buy | |
PMVP PMV Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.13
| $5.00 | Buy ➝ Buy | |
PPTA Perpetua Resources | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.73
+4.9% | $10.50 ➝ $13.25 | Buy ➝ Buy | |
PRAX Praxis Precision Medicines | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.15
-0.1% | $105.00 | Buy ➝ Buy | |
PSFE Paysafe | Target Raised by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.18
+16.0% | $14.00 ➝ $16.00 | Neutral ➝ Neutral | |
PSFE Paysafe | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.18
+16.0% | $16.00 ➝ $20.00 | Sector Perform ➝ Sector Perform | |
PSX Phillips 66 | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $145.06
0.0% | $187.00 ➝ $170.00 | Overweight ➝ Overweight | |
PWSC PowerSchool | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.27
+1.8% | $26.00 | Buy ➝ Buy | |
QBTS D-Wave Quantum | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.36
-1.1% | $2.50 | Buy ➝ Buy | |
RAPT RAPT Therapeutics | Reiterated by | Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.04
-8.2% | | Outperform ➝ Peer Perform | |
RBLX Roblox | Reiterated by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.63
+2.2% | $55.00 ➝ $35.00 | Buy ➝ Neutral | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
RCEL AVITA Medical | Target Lowered by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.75
+4.8% | $22.00 ➝ $21.00 | Overweight ➝ Overweight | |
RCEL AVITA Medical | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.75
+4.8% | $21.00 ➝ $9.00 | Overweight ➝ Neutral | |
RCL Royal Caribbean Cruises | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.12
+0.2% | $154.00 ➝ $168.00 | Buy ➝ Buy | |
REGN Regeneron Pharmaceuticals | Initiated by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $983.16
+0.6% | $1,150.00 | Outperform | |
RITM Rithm Capital | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.40
+0.8% | $10.50 ➝ $12.50 | Neutral ➝ Neutral | |
ROK Rockwell Automation | Target Lowered by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $271.19
+0.8% | $300.00 ➝ $290.00 | Hold ➝ Hold | |
RPHM Reneo Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.61
+1.3% | $1.50 | Neutral ➝ Neutral | |
SAM Boston Beer | Upgraded by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $285.09
+0.4% | $335.00 ➝ $360.00 | Hold ➝ Buy | |
SAVE Spirit Airlines | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.59
+4.6% | $3.85 ➝ $3.50 | Sell ➝ Sell | |
SE SEA | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.88
+3.8% | $72.00 | Outperform ➝ Outperform | |
SFL SFL | Target Raised by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.14
-1.4% | $15.00 ➝ $16.00 | Buy ➝ Buy | |
SFM Sprouts Farmers Market | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.64
+0.7% | $68.00 ➝ $70.00 | In-Line ➝ In-Line | |
SHIM Shimmick | Downgraded by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.61
-28.3% | $10.00 ➝ $4.00 | Buy ➝ Hold | |
SHIM Shimmick | Downgraded by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.61
-28.3% | $9.00 ➝ $3.50 | Buy ➝ Neutral | |
SHW Sherwin-Williams | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $313.90
-0.6% | $360.00 ➝ $365.00 | Outperform ➝ Outperform | |
SNSE Sensei Biotherapeutics | Initiated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.55
-1.6% | $5.00 | Overweight | |
SPRB Spruce Biosciences | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.82
+1.6% | | Neutral | |
SPSC SPS Commerce | Initiated by | Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $194.47
+1.0% | $220.00 | Buy | |
SQSP Squarespace | Reiterated by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.25
| $43.00 ➝ $44.00 | Buy ➝ Neutral | |
SQSP Squarespace | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.25
| $40.00 ➝ $44.00 | Equal Weight ➝ Equal Weight | |
SRPT Sarepta Therapeutics | Upgraded by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $132.58
+0.7% | $180.00 | Market Perform ➝ Outperform | |
SSTK Shutterstock | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.94
+2.9% | $65.00 | Buy ➝ Buy | |
STIM Neuronetics | Upgraded by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.52
-1.6% | | Market Perform ➝ Outperform | |
STRO Sutro Biopharma | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.35
+2.8% | $8.00 | Outperform ➝ Outperform | |
STRO Sutro Biopharma | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.35
+2.8% | $12.00 | Buy ➝ Buy | |
STTK Shattuck Labs | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.82
-14.8% | $12.00 | Buy ➝ Buy | |
STX Seagate Technology | Initiated by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.62
+2.7% | $110.00 | Buy | |
TBNK Territorial Bancorp | Target Lowered by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.38
-0.1% | $10.00 ➝ $9.66 | Market Perform ➝ Market Perform | |
TBPH Theravance Biopharma | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.44
-1.5% | $20.00 | Buy ➝ Buy | |
TCRX TScan Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.77
+9.5% | $15.00 | Buy ➝ Buy | |
TDOC Teladoc Health | Target Lowered by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.72
+2.2% | $16.50 ➝ $13.50 | Neutral ➝ Neutral | |
TENB Tenable | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.81
-0.2% | $62.00 | Buy ➝ Buy | |
TERN Terns Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.94
+0.8% | $5.50 | Neutral ➝ Neutral | |
TFC Truist Financial | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.33
+0.4% | $38.00 ➝ $41.00 | Neutral ➝ Neutral | |
TKNO Alpha Teknova | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.96
+12.6% | $15.00 | Overweight ➝ Overweight | |
TME Tencent Music Entertainment Group | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.62
-1.2% | $14.00 ➝ $19.00 | Buy ➝ Buy | |
TREX Trex | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $87.93
+0.4% | $105.00 | Buy ➝ Buy | |
TRML Tourmaline Bio | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $14.68
+1.7% | $48.00 | Buy ➝ Buy | |
TRNO Terreno Realty | Target Lowered by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.28
+0.7% | $68.00 ➝ $60.00 | Neutral ➝ Neutral | |
TSCO Tractor Supply | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $275.63
+1.5% | $285.00 ➝ $290.00 | Outperform ➝ Outperform | |
TSHA Taysha Gene Therapies | Reiterated by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.58
+7.5% | $2.00 ➝ $8.00 | Hold ➝ Buy | |
UDR UDR | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.31
+0.5% | $39.00 ➝ $42.00 | Sector Perform ➝ Sector Perform | |
UDR UDR | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.31
+0.5% | $37.00 ➝ $40.00 | Equal Weight ➝ Equal Weight | |
ULTA Ulta Beauty | Target Lowered by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $404.18
+0.1% | $605.00 ➝ $476.00 | Neutral ➝ Neutral | |
ULTA Ulta Beauty | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $404.18
+0.1% | $565.00 ➝ $475.00 | Hold ➝ Hold | |
ULY Urgent.ly | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.09
-2.8% | $5.00 | Buy ➝ Buy | |
UNCY Unicycive Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.08
-0.9% | $4.50 | Buy ➝ Buy | |
URGN UroGen Pharma | Target Lowered by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.88
-1.5% | $34.00 ➝ $32.00 | Outperform ➝ Outperform | |
URGN UroGen Pharma | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.88
-1.5% | $54.00 | Buy ➝ Buy | |
VCTR Victory Capital | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.02
+0.3% | $47.00 ➝ $56.00 | Outperform ➝ Outperform | |
VERU Veru | Initiated by | B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.44
+7.9% | $5.00 | Buy | |
VET Vermilion Energy | Initiated by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.99
+1.3% | | Outperform | |
VLO Valero Energy | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $154.91
-0.7% | $198.00 ➝ $187.00 | Overweight ➝ Overweight | |
VRCA Verrica Pharmaceuticals | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.85
+3.0% | $8.00 ➝ $16.00 | Buy ➝ Buy | |
VRCA Verrica Pharmaceuticals | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.85
+3.0% | $13.00 ➝ $14.00 | Buy ➝ Buy | |
VTEX VTEX | Upgraded by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.28
+11.1% | $9.00 ➝ $9.00 | Neutral ➝ Overweight | |
VTLE Vital Energy | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.94
+1.2% | $57.00 ➝ $54.00 | Equal Weight ➝ Equal Weight | |
VYGR Voyager Therapeutics | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.45
-0.4% | $10.00 ➝ $8.00 | Neutral ➝ Neutral | |
WDC Western Digital | Initiated by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.58
+2.3% | $90.00 | Buy | |
WFRD Weatherford International | Initiated by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $123.56
+0.7% | $155.00 | Buy | |
WMT Walmart | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.87
-0.9% | $66.00 ➝ $67.00 | Outperform ➝ Outperform | |
WSM Williams-Sonoma | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $316.80
+0.4% | $310.00 ➝ $315.00 | In-Line ➝ In-Line | |
XGN Exagen | Target Raised by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.97
+19.9% | $5.00 ➝ $7.00 | Overweight ➝ Overweight | |
XPRO Expro Group | Upgraded by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.66
+2.4% | $18.00 ➝ $27.00 | Equal Weight ➝ Overweight | |
ZS Zscaler | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $176.36
+0.8% | $270.00 | Market Outperform ➝ Market Outperform | |
